Clinical Trials Logo

Clinical Trial Summary

Activated charcoal (AC) is an established, effective means of gastrointestinal decontamination. Providers give it to patients who have ingested something that is thought to be potentially poisonous to prevent it from being absorbed. However, one limitation to its use is palatability of the AC for the patient, potentially limiting how much, if any, is taken. Other studies have suggested that mixing AC with various substances improves the rating on various scales (taste, etc). An important question is whether mixing the AC with other substance effects the ability of the AC to bind to xenobiotic in the gut. This small study investigates whether mixed cola with charcoal affected its ability to prevent the absorption of acetaminophen. It also performs a survery to see if participants preferred the AC-cola mixture. The investigators hypothesize that the AC will be equally as effective with cola as without. The investigators also hypothesize that participants will prefer the AC-cola mixture.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06219967
Study type Interventional
Source State University of New York - Upstate Medical University
Contact
Status Completed
Phase Phase 4
Start date January 4, 2023
Completion date March 14, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05786222 - Permanent Supportive Housing Overdose Prevention N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT01050270 - Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP) Phase 4
Recruiting NCT05343169 - Community-based Education, Navigation, and Support Intervention for Military Veterans N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT03402672 - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users N/A
Completed NCT03337100 - The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy N/A
Enrolling by invitation NCT05776823 - Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD) N/A
Not yet recruiting NCT06316739 - The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City N/A
Completed NCT03107689 - Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
Completed NCT02101424 - Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department N/A
Completed NCT03518021 - Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital Phase 3
Not yet recruiting NCT06236087 - Overdose Prevention Centers and Behavioral Health
Completed NCT04212364 - An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses N/A
Completed NCT04953338 - Mental Health Associations With Vitiligo
Active, not recruiting NCT06456294 - Evaluation of a Medication Health Center to Promote Opioid Safety N/A
Completed NCT03908437 - Rapid Initiation of Drug Treatment Engagement Phase 4
Recruiting NCT05886712 - Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs (SAIA-Naloxone) N/A
Completed NCT04797221 - Emergency Room Firearm and Medication Safety Intervention
Recruiting NCT06216327 - Safety Planning 6+ N/A